Description
Description
Lenvakast-10mg
Composition: Lenvatinib 10mg
Therapeutic Class: Antineoplastic
Aprazer’s Lenvakast: Globally Prescribed and Trusted
Aprazer Healthcare is the leading global pharmaceutical company that manufactures a range of oncology care therapeutics.
- • WHO–GMP certified, Affordable oncology Medicines
- • Reaching the global markets, Aprazer Healthcare products are available worldwide.
- • Africa, South America, Southeast Asia, CIS countries.
What is Lenvakast?
Lenvakast is lenvatinib, which is used to treat several advanced-stage or metastatic cancers.
Uses of Lenvakast
- • Advanced Kidney Cancer
- • Radioactive Iodine-refractory Differentiated Thyroid Cancer
- • Advanced Hepatocellular Carcinoma
- • Endometrial Carcinoma
How does Lenvakast work?
- • It is a multiple tyrosine kinase inhibitor
- • It blocks several kinase enzymes
- • Inhibits new blood vessel formation in cancer cells
- • Cause cancer cells to starve and die.
Common Side Effects Include
- • High BP
- • Tiredness
- • Diarrhea
- • Nausea
- • Loss of appetite
- • Weight decline
- • Hand and foot syndrome
- • Pain in muscles and joints
Serious Side Effects
These are dose-dependent side effects that can be managed by supportive care.
- • Dizziness, seizures, and confusion.
- • Stroke or heart failure.
- • Elevated liver enzymes, acute liver failure.
- • GIT perforations
- • Internal bleeding
- • Thrombosis
Precautions
To be cautiously used in patients with:
- • Heart disease
- • Renal disorder
- • Liver disorder
Contraindications
- • Not to be used if any previous allergy or hypersensitivity to lenvatinib or any excipients.
- • Breastfeeding mothers
- • Pregnant women
Warning
To be used under medical prescription only.
Important Safety and Monitoring Information
Regular monitoring of the liver function, cardiac functions, blood pressure, neurological condition, and renal function.
Download Product PDF Attachment
